AHA urges Labor Department to investigate MultiPlan's 'unconscionable practices’

The latest stories trending on MedCity News.

Editor's Pick

Top Story AHA Urges Labor Department to Investigate MultiPlan's 'Unconscionable Practices' Following an extensive investigative report from the New York Times, the AHA is calling for the Labor Department to probe into the business practices of data analytics firm MultiPlan. The report revealed that MultiPlan works with major payers to negotiate reduced reimbursements for out-of-network medical providers — and that this practice ends up costing patients and employers. Sponsored Content Ardent Health chooses innovative Employee Benefits and Employee Experience with Quantum Health and Imagine360 Presented by Quantum Health Ardent Health Services, a prominent national health system, has recently introduced a cutting-edge health benefits program to benefit 23,000 Ardent employees and their families. This innovative initiative is the result of an exclusive collaboration between Quantum Health and Imagine360, harnessing Quantum Health's advanced healthcare navigation and care coordination services alongside Imagine360's top-tier network and cost-saving measures. These Startups Will Present At INVEST 2024 Have you heard? The following startups are the selected finalists for the payer/provider track at INVEST 2024: Samaritan, Syntax Health, Somnea Health, Healcisio, Kemtai, and DNASafe. Their health tech solutions span a wide range of areas such as physical therapy, critical illness, health data privacy, as well as solutions to burnout and operational efficiency and more. Join us May 21-22 and create opportunities. Get Your Tickets Now

Featured News

Grow Therapy Secures $88M To Expand Mental Health Services Grow Therapy's $88 million Series C funding round was led by Sequoia Capital. The financing will help the company invest in its team, improve its product and expand its footprint. Novartis Pays $150M to Nab a Phase 3-Ready Protein Degrader for Prostate Cancer Novartis gains global rights to an Arvinas protein degrading drug that targets the androgen receptor to treat prostate cancer. The deal also includes a preclinical molecule addressing an androgen receptor variant. Health Benefit Consultants, Share Your Expert Insights in Our Survey Share some of the trends you are seeing among your clients across healthcare, including chronic conditions, behavioral health, healthcare navigation, and more.  A Guide for Specialty Practices Navigating a Future of Healthcare that Does Good and Feels Good As the healthcare evolves toward service-based models, providers increasingly look to balance service delivery demands while keeping their core medical values without yielding to an overburdened system's pressures.

Resources

A Conversation About Wearable Robots with Scott Davis In this final episode of Season 1, which focuses on the world of medtech, Scott Davis, CEO of Ekso Bionics, delves into the history of the company and the novel devices that Ekso has built. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe